TScan Therapeutics
target is a cancer testis antigen expressed in various cancers but not healthy tissue scan | TScan Therapeutics
Company
Deck Type
IPO
Sector
Industry
Deck date
July 2021
Slide
33 of 43
Related slides by other companies
SentiBio
SPAC
October 2021
senti discovered as a safety antigen that is highly expressed in healthy epithelial cells but not in tumor cells | SentiBio
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights